Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 241-250 of 313 for Lung cancer

Edit search filters
  1. CASCADE-LUNG: Cancer Screening Assay Using DELFI; A Clinical Validation Study in Lung (DELFI-L201)

    Rochester, MN

  2. Study to Determine Eligibility for Lung Cancer Screening in Patients with Acute or Prior Cerebrovascular Accident (CVA)

    Jacksonville, FL

  3. A Study to Collect Medical Data and Tissue from Patients with Lung Conditions Resulting in Lung Surgery.

    Rochester, MN

  4. A Multi-Center Trial of the ProLung Test™

    Rochester, MN

  5. Molecular Analysis to Drive Individualized Care in Lung Cancer

    Rochester, MN

  6. Metastatic Non-Small Cell Lung Cancer Insomnia

    Rochester, MN

  7. Screening for High Frequency Malignant Disease

    Rochester, MN, Eau Claire, WI, La Crosse, WI

  8. Treatment of Multifocal Lung Adenocarcinoma

    Rochester, MN

  9. A Study to Evaluate DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study

    Rochester, MN

  10. Identification of a Plasma Proteomic Signature for Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer